These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3139859)

  • 1. A pharmacokinetic model for percutaneous absorption of valproic acid and prediction of drug disposition.
    Ogiso T; Ito Y; Iwaki M; Atago H; Yamamoto Y
    J Pharmacobiodyn; 1988 Jun; 11(6):444-52. PubMed ID: 3139859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous absorption of valproic acid and its plasma concentration after application of ointment.
    Ogiso T; Ito Y; Iwaki M; Yamamoto Y; Yamahata T
    J Pharmacobiodyn; 1987 Oct; 10(10):537-42. PubMed ID: 3126287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug disposition kinetics.
    Ogiso T; Ito Y; Iwaki M; Atago H
    J Pharm Sci; 1989 Apr; 78(4):319-23. PubMed ID: 2724095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The percutaneous absorption of propranolol and prediction of the plasma concentration.
    Ogiso T; Ito Y; Iwaki M; Shintani A
    J Pharmacobiodyn; 1988 May; 11(5):349-55. PubMed ID: 3171877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a single dose of ethanol on the kinetics of valproic acid in rats.
    Alonso IG; Lanao JM; Martin MI; Mateos A; Dominguez-Gil Hurlé A; Fermoso J
    Drug Metab Dispos; 1990; 18(5):732-4. PubMed ID: 1981728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
    Dahan A; Duvdevani R; Shapiro I; Elmann A; Finkelstein E; Hoffman A
    J Control Release; 2008 Feb; 126(1):1-9. PubMed ID: 18082281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous absorption of pindolol and pharmacokinetic analysis of the plasma concentration.
    Ogiso T; Iwaki M; Tanino T; Oue H
    J Pharmacobiodyn; 1992 Jul; 15(7):347-52. PubMed ID: 1447682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex related differences on valproic acid pharmacokinetics after oral single dose.
    Ibarra M; Vázquez M; Fagiolino P; Derendorf H
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):479-86. PubMed ID: 23784346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of low levels of plasma valproic acid concentration following simultaneous administration of sodium valproate and rizatriptan benzoate.
    Hokama N; Hobara N; Kameya H; Ohshiro S; Hobara N; Sakanashi M
    J Pharm Pharmacol; 2007 Mar; 59(3):383-6. PubMed ID: 17331341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transdermal delivery of drugs and enhancement of percutaneous absorption].
    Ogiso T; Tanino T
    Yakugaku Zasshi; 2000 Apr; 120(4):328-38. PubMed ID: 10774255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of administration route on valproate pharmacokinetics in the rabbit.
    Bourin M; Guenzet J; Thomare P; Kergueris MF; Ortega A; Larousse C
    Fundam Clin Pharmacol; 1991; 5(4):331-9. PubMed ID: 1916614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo microdialysis for the transdermal absorption of valproate in rats.
    Matsuyama K; Nakashima M; Ichikawa M; Yano T; Satoh S; Goto S
    Biol Pharm Bull; 1994 Oct; 17(10):1395-8. PubMed ID: 7874063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions.
    Booth CL; Pollack GM; Brouwer KL
    Hepatology; 1996 Apr; 23(4):771-80. PubMed ID: 8666331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
    Dutta S; Reed RC; O'Dea RF
    Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of plasma concentration profile during single and repeated skin applications of indomethacin and its calcium salt ointments.
    Ogiso T; Ito Y; Iwaki M; Atago H
    J Pharmacobiodyn; 1987 Aug; 10(8):384-9. PubMed ID: 3694433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variation of Valproic acid pharmacokinetics in mice.
    Ben-Cherif W; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
    Eur J Pharm Sci; 2013 Jul; 49(4):468-73. PubMed ID: 23707469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ohdo S; Ogawa N
    J Pharmacobiodyn; 1992 Aug; 15(8):403-8. PubMed ID: 1479540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of carbamazepine on valproic acid disposition in adult volunteers.
    Panesar SK; Orr JM; Farrell K; Burton RW; Kassahun K; Abbott FS
    Br J Clin Pharmacol; 1989 Mar; 27(3):323-8. PubMed ID: 2497766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.
    Gynther M; Peura L; Vernerová M; Leppänen J; Kärkkäinen J; Lehtonen M; Rautio J; Huttunen KM
    Neurochem Res; 2016 Oct; 41(10):2797-2809. PubMed ID: 27412117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.